Hengerer, F. H., Auffarth, G. U., Riffel, C., & Conrad-Hengerer, I. (2019). Second-Generation Trabecular Micro-Bypass Stents as Standalone Treatment for Glaucoma: A 36-Month Prospective Study. Adv Ther.
Chicago-tyylinen lähdeviittausHengerer, Fritz H., Gerd U. Auffarth, Christoffer Riffel, ja Ina Conrad-Hengerer. "Second-Generation Trabecular Micro-Bypass Stents As Standalone Treatment for Glaucoma: A 36-Month Prospective Study." Adv Ther 2019.
MLA-viiteHengerer, Fritz H., Gerd U. Auffarth, Christoffer Riffel, ja Ina Conrad-Hengerer. "Second-Generation Trabecular Micro-Bypass Stents As Standalone Treatment for Glaucoma: A 36-Month Prospective Study." Adv Ther 2019.
Varoitus: Nämä viitteet eivät aina ole täysin luotettavia.